MSCs-derived exosomes (Cellular Biomedicine)

N/A

Report date: 2025/02/28 10:17:52

Base Information

Drug NameMSCs-derived exosomes (Cellular Biomedicine)
Drug Alias NameAllogeneic Human Adipose-derived Mesenchymal Progenitor Cell Exosomes(Cellular Biomedicine)ahaMSCs-Exo(Cellular Biomedicine)
ClassificationBiologics > Exosomes > Stem cell-derived exosomes
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAlzheimer DiseaseRespiratory Distress Syndrome, AdultCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCellular Biomedicine Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCellular Biomedicine Group Ltd
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, Adult
Inactive IndicationsAlzheimer DiseaseCoronavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A